Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a .
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformationNet proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation prioritiesEstablishes a diversified.
PDF - 2023-05-08 Baxter International Inc. , a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma. | May 8, 2023